The translation factor eIF4E is a key mediator of doxorubicin resistance: insights from a triple-negative breast cancer model.
- DOI
- 10.1038/s41598-025-31313-6
- Published
- 2026 Jan 7
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-025-31313-6,
title = {The translation factor eIF4E is a key mediator of doxorubicin resistance: insights from a triple-negative breast cancer model.},
author = {Frayde-Gómez H and Chimal-Vega B and Pulido-Capiz A and Muñoz-Ayala A and Galindo-Hernández O and Vique-Sanchez JL and Leija-Montoya AG and Díaz-Molina R and Madero-Ayala PA and Ramos-Ibarra MA and García-González V},
year = {2026},
journal = {Scientific reports},
doi = {10.1038/s41598-025-31313-6},
url = {https://doi.org/10.1038/s41598-025-31313-6}
}RIS
TY - JOUR TI - The translation factor eIF4E is a key mediator of doxorubicin resistance: insights from a triple-negative breast cancer model. AU - Frayde-Gómez H AU - Chimal-Vega B AU - Pulido-Capiz A AU - Muñoz-Ayala A AU - Galindo-Hernández O AU - Vique-Sanchez JL AU - Leija-Montoya AG AU - Díaz-Molina R AU - Madero-Ayala PA AU - Ramos-Ibarra MA AU - García-González V PY - 2026 JO - Scientific reports DO - 10.1038/s41598-025-31313-6 UR - https://doi.org/10.1038/s41598-025-31313-6 ER -
APA
H, F., B, C., A, P., A, M., O, G., JL, V., AG, L., R, D., PA, M., MA, R., & V, G. (2026). The translation factor eIF4E is a key mediator of doxorubicin resistance: insights from a triple-negative breast cancer model.. Scientific reports. https://doi.org/10.1038/s41598-025-31313-6
Source records
- pubmed · retrieved 2026-09-26T06:08:29.193Z